Lanfermeijer, Josien
van de Ven, Koen http://orcid.org/0000-0001-7549-5683
van Dijken, Harry
Hendriks, Marion
Talavera Ormeño, Cami M. P. http://orcid.org/0000-0001-5502-2985
de Heij, Femke
Roholl, Paul
Borghans, José A. M.
van Baarle, Debbie
de Jonge, Jørgen http://orcid.org/0000-0003-3167-2435
Article History
Received: 19 February 2022
Accepted: 11 July 2023
First Online: 12 August 2023
Competing interests
: J.L. is currently working at AstraZeneca the Netherlands. However, when performing this research and while writing the first version of the manuscript, this was not the case. All the other authors declare no competing interests.